Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
PRILOZI
Volume 42 (2021): Numero 1 (April 2021)
Accesso libero
Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021)
Irina Panovska-Stavridis
Irina Panovska-Stavridis
,
Nevenka Ridova
Nevenka Ridova
,
Tatjana Stojanoska
Tatjana Stojanoska
,
Ilir Demiri
Ilir Demiri
,
Milena Stevanovic
Milena Stevanovic
,
Simona Stojanovska
Simona Stojanovska
,
Tara Ristevska
Tara Ristevska
,
Aleksandar Dimkovski
Aleksandar Dimkovski
,
Venko Filipce
Venko Filipce
,
Aleksandar Dimovski
Aleksandar Dimovski
e
Aleksandra Grozdanova
Aleksandra Grozdanova
| 23 apr 2021
PRILOZI
Volume 42 (2021): Numero 1 (April 2021)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
23 apr 2021
Pagine:
5 - 18
DOI:
https://doi.org/10.2478/prilozi-2021-0001
Parole chiave
SARS-CoV-2
,
COVID-19
,
pandemic
,
antiviral drugs
,
immunomodulatory drugs
,
remdesivir
© 2021 Irina Panovska-Stavridis et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Irina Panovska-Stavridis
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius
Skopje
Nevenka Ridova
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius
Skopje
Tatjana Stojanoska
University Clinic of Infection Diseases and Febrile Conditions, Faculty of Medicine, University Ss. Cyril and Methodius
Skopje
Ilir Demiri
University Clinic of Infection Diseases and Febrile Conditions, Faculty of Medicine, University Ss. Cyril and Methodius
Skopje
Milena Stevanovic
University Clinic of Infection Diseases and Febrile Conditions, Faculty of Medicine, University Ss. Cyril and Methodius
Skopje
Simona Stojanovska
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius
Skopje
Tara Ristevska
University Clinic of Hematology, Medical Faculty, University Ss. Cyril and Methodius
Skopje
Aleksandar Dimkovski
Faculty of Pharmacy, University Ss. Cyril and Methodius
Skopje
Venko Filipce
University Clinic for Neurosurgery, Faculty of Medicine, University Ss. Cyril and Methodius
Skopje
Aleksandar Dimovski
Faculty of Pharmacy, University Ss. Cyril and Methodius
Skopje
Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Sciences and Arts
Skopje
Aleksandra Grozdanova
Faculty of Pharmacy, University Ss. Cyril and Methodius
Skopje